NHS analytics officials and other staff have reported being warned by senior leaders that continued public criticism of Palantir’s Federated Data Platform (FDP) could cost them their jobs, according to a Financial Times investigation.
The investigation highlights deepening tensions within England’s health service over the £330 million, seven-year contract awarded to the US data analytics firm in 2023.
While the platform aims to unify fragmented NHS data, from patient waiting lists and operating theatre schedules to staff rosters, its rollout has sparked ethical objections, questions about value for money, and resistance from some frontline teams.
One NHS analytics official, speaking anonymously to protect his position, described receiving a direct phone call from a senior NHS England figure involved in the procurement: “If you criticise the FDP one more time, you are going to lose your job.”
The official had openly questioned the need for the technology at the hospital where he works, even after its initial rollout last year. He added that he believes he is not alone, with others inside the NHS also feeling pressured to stay silent on the issue.
A second official recounted being summoned to a meeting with senior NHS England leadership and told that an in-house data tool they were developing would be superseded by the FDP.
They were warned that leadership would speak to their boss to ensure the work stopped, a conversation the source described as delivering “a very real threat,” with colleagues advising them to “watch yourself.”
A controversial deal
The FT report comes amid a series of challenges to the deal. Recent coverage has highlighted staff boycotts, coalition campaigns urging trusts to reject the platform on ethical and data-risk grounds, and debates over whether Palantir contractors should receive NHS email accounts.
Greater Manchester’s integrated care board, for instance, has deferred adoption, citing limited added value and public trust risks.
Critics argue the top-down push risks damaging staff morale and trust in NHS data initiatives at a time when the health service faces immense operational pressures.
Supporters counter that unified data analytics are essential for tackling waiting lists, improving efficiency, and delivering better patient outcomes in a cash-strapped system.
As the contract approaches its review point, the debate over Palantir’s role in the NHS is likely to intensify, pitting promises of technological efficiency against concerns over ethics, autonomy, and the long-term implications of outsourcing core data infrastructure to a controversial private provider.
Leave a Reply